Levosimendan for VA-ECMO weaning: the silver lining

ESC Heart Fail. 2022 Feb;9(1):236-240. doi: 10.1002/ehf2.13751. Epub 2021 Dec 6.

Authors

Rasha Kaddoura¹, Mohamed Izham Mohamed Ibrahim², Amr Omar³

Affiliations

¹ Department of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
² Medical and Health Sciences Office, College of Pharmacy, QU Health, Qatar University, Doha, Qatar.
³ Department of Cardiothoracic Surgery/Cardiac Anaesthesia, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.

No abstract available

Publication types

Letter
Comment

MeSH terms

Extracorporeal Membrane Oxygenation*
Humans
Shock, Cardiogenic
Simendan / therapeutic use

Substances

Simendan